Diagnostic value of procalcitonin in pleural effusions

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 3, 2011, Pages 313-318

  Wang, C Y ^a   Hsiao, Y C ^b   Jerng, J S ^c   Ho, C C ^c   Lai, C C ^a   Yu, C J ^c   Hsueh, P R ^c   Yang, P C ^c  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EMPYEMA; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURA EFFUSION; PARAPNEUMONIC EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TRANSUDATIVE PLEURA EFFUSION; TUBERCULOUS PLEURISY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; EMPYEMA; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PNEUMONIA; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PLEURAL;

EID: 79951723356     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1082-0     Document Type: Article

References (21)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518 (Pubitemid 23066085)
2. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27:498-504 (Pubitemid 29162669)
3. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J (1999) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3:45-55
4. Luyt CE, Guerin V, Combes A et al (2005) Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 171:48-53 (Pubitemid 40051694)
5. Brunkhorst FM, Eberhard OK, Brunkhorst R (1999) Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 27:2172-2176 (Pubitemid 29508332)
6. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomized, single-blinded intervention trial. Lancet 363:600-607 (Pubitemid 38264177)
7. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr (1972) Pleural effusion: the diagnostic separation of transudates and exudates. Ann Intern Med 77:507-513
8. Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-González A, Martínez-Iribarren A et al (2009) Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 34:1383-1389
9. Lin MC, Chen YC, Wu JT, Ko YC, Wang CC (2009) Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions. Chest 136:205-211
10. Baylan O, Balkan A, Inal A, Kisa O, Albay A, Doganci L et al (2006) The predictive value of serum procalcitonin levels in adult patients with active pulmonary tuberculosis. Jpn J Infect Dis 59:164-167 (Pubitemid 43959973)
11. Nyamande K, Lalloo UG (2006) Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP. Int J Tuberc Lung Dis 10:510-515 (Pubitemid 43667638)
12. Schleicher GK, Herbert V, Brink A, Martin S, Maraj R, Galpin JS et al (2005) Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J 25:688-692 (Pubitemid 40528763)
13. Cakir E, Deniz O, Ozcan O, Tozkoparan E, Yaman H, Akgul EO et al (2005) Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy. Clin Biochem 38:234-238 (Pubitemid 40222322)
14. Ho CC, Liao WY, Wang CY, Lu YH, Huang HY, Chen HY et al (2008) TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med 177:763-770
15. Topolcan O, Holubec L, Polivkova V, Svobodova S, Pesek M, Treska V et al (2007) Tumor markers in pleural effusions. Anticancer Res 27:1921-1924 (Pubitemid 46954699)
16. Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R (2004) A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology 9:66-69 (Pubitemid 38647772)
17. Garcia-Pachon E, Llorca I (2002) Diagnostic value of C-reactive protein in exudative pleural effusions. Eur J Intern Med 13:246-249 (Pubitemid 34627054)
18. Chan MC, Chang KM, Chao WC, Lin LY, Kuo BI, Hsu JY et al (2007) Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology 12:333-338 (Pubitemid 47164769)
19. Liu CL, Hsieh WY, Wu CL, Kuo HT, Lu YT (2007) Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med 101:903-909
20. Becker KL, Nylén ES, White JC, Müller B, Snider RH Jr (2004) Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512-1525 (Pubitemid 38507896)
21. Leon ALC, Cousson J, Raclot P, Suinat JL, Assicot M, Bohuon C (1995) 5th Vienna Shock Forum. Vienna, Austria, May 7-11, 1995. Abstracts. Shock 3 [Suppl]:1-84